B
ile acids are potent detergents and are essential for efficient digestion and absorption of dietary fat. Bile acids are synthesized by the liver from cholesterol, excreted into bile, and stored in the gallbladder. After ingestion of a fatcontaining diet, the gallbladder contracts, forcing bile to enter the lumen of the proximal duodenum. Lipids in bile acid emulsions are absorbed in the proximal jejunum, whereas the majority of bile acids are absorbed in distal ileum, whereupon they are transported back to the liver through the portal blood. Each cycle of the bile acid enterohepatic circulation pathway is associated with a small (Ϸ5%) loss, which is replaced through de novo hepatic synthesis (1) .
The same amphipathic properties that allow bile acids to emulsify lipids also make them membrane-disruptive agents (2) . Thus, limiting the accumulation of bile acids within cells making up the enterohepatic circulation helps to prevent cytotoxicity. Because bile acids have vastly different structures and abilities to emulsify lipids (2), the composition of the bile acid pool can markedly influence their ability to facilitate lipid digestion and absorption.
The itinerary of bile acids involves transport across apical and basolateral surfaces of cells in the liver (hepatocytes) and intestine (enterocytes) (Fig.  1) . Identification of the apical ileal sodium-dependent bile acid transporter (Asbt) explained how bile acids are efficiently reabsorbed by the ileal epithelial cell (3). This discovery stimulated the search for a transporter that would efficiently transport bile acids across the basolateral surface membrane of the ileal enterocyte.
In a recent issue of PNAS, Rao et al. (4) identify Ost␣/Ost␤ as the heterodimeric bile acid transporter responsible for the basolateral transport of bile acids out of the ileal epithelial cell. The new insights provided by these studies provide an integrated pathway through which the expression of multiple distinct high-affinity bile acid transporters efficiently retrieves bile acids from the distal ileum and delivers them to the liver.
The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily and, as a heterodimer with RXR, is activated by bile acids. Because FXR induces the expression of Ost␣ and Ost␤, it seemed plausible that the Ost␣/␤ heterodimer could be the ileal basolateral bile acid transporter (5) . Whereas cell culture studies showed that coexpression of Ost␣ and Ost␤ could enhance the apical-to-basolateral transport of taurocholate, it was not clear that this is the major transporter responsible for basolateral ileal bile acid transport in vivo (6) . The studies of Rao et al. (4) clearly show that the expression of Ost␣ is necessary for the heterodimeric complex Ost␣/Ost␤ to be expressed at the basolateral surface and for the bile acids to be efficiently absorbed in mice. Moreover, using everted gut sacs, Rao et al. show that the transileal transport of taurocholate is reduced by Ͼ80% in Ost␣ Ϫ/Ϫ mice vs. sacs from wild-type mice. These data clearly establish the Ost␣/␤ heterodimer as the major transporter responsible for the ileal basolateral transport of bile acids.
A parallel story involves the mechanism by which bile acid levels in the enterocytes synchronize bile acid production in hepatocytes. This story emerges from the paradoxical observation that although feeding animals diets enriched in bile acids suppresses their own production by decreasing CYP7A1 expression, adding bile acids to the medium of isolated hepatocytes has no effect (7). FXR is essential for bile acid feedback regulation through the suppression of Cyp7a1 expression, but quite surprisingly, it is intestinal FXR, not hepatic FXR, that mediates the tuning of this pathway (8) . The abilities of individual bile acids to activate FXR (9, 10) correlate with their detergent properties (2). Thus, nonamphipathic bile acids (ursodeoxycholic acid) neither activate FXR nor are helpful in digestion and absorption of lipids. Uptake of bile acids that activate FXR by the ileal enterocyte induces the expression of fibroblast growth factor is (FGF15) (11) (12) (13) . FGF15 is released into the portal circulation and then binds to the hepatocyte basolateral receptor FGFR4, leading to the repression of Cyp7A1 expression (8, (12) (13) (14) (15) . In short, FGF15 is the link between FXR sensing of bile acids in enterocytes and expression of Cyp7A1 in hepatocytes. Rao et al. (4) show that the expression of Asbt, Ost␣/␤, and FGF15 is confined mainly to enterocytes located in a fairly narrow portion located in the distal ileum. Thus, a distinct population of intestinal epithelial cells is responsible for the FGF15-mediated communication between the intestine and the liver.
Because ileal FXR acts as a bile acid sensor, this pathway synchronizes hepatic bile acid production to the enterocyte bile acid pool size. Accordingly, reduction of the enterocyte bile acid pool size by deletion of the apical bile acid transporter, Asbt, leads to an induction of hepatic Cyp7A1 (16). Conversely, Rao et al. (4) show that deletion of Ost␣ increases the enterocyte bile acid pool size, but reduces the overall bile acid pool size, because of the repression of Cyp7A1. Furthermore, the inability of nonamphipathic bile acids to activate FXR in the distal ileal epithelial cell would prevent FXR-mediated induction of FGF15 and repression of CYP7A1. As a result, enhanced expression of CYP7A1 would increase the production of primary amphipathic bile acids (e.g., cholic and chenodeoxycholic acids), thus maintaining the composition of the bile acid pool in a manner that ensures efficient digestion and absorption of lipids.
These findings expose the complex circuitry through which the amount and composition of bile acids recovered by the distal ileal epithelial cell adjusts de novo hepatic bile acid synthesis, thus promoting efficient digestion and absorption of essential lipid nutrients by maintaining both the size and the composition of the bile acid pool.
